BPBT
PETX

Boston Private Bank & Trust’s Aratana Therapeutics, Inc. PETX Stock Holding History

Boston Private Bank & Trust’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$13K Hold
835
– – ﹤0.01% 786
2014
Q4 		$15K Buy
+835
New +$10.4K ﹤0.01% 798

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Private Bank & Trust's PETX Position: Q1 2015 in Review

Boston Private Bank & Trust held its Aratana Therapeutics, Inc. (PETX) position steady in Q1 2015 at 835 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #786.

Boston Private Bank & Trust first reported a position in PETX in Q4 2014 and has held it in 2 quarters since. The position peaked at $15K in Q4 2014. 93 funds tracked by Wall St. Rank hold PETX as of Q1 2015.

  • Boston Private Bank & Trust held 835 shares of Aratana Therapeutics, Inc. worth $13K as of Q1 2015.
  • Boston Private Bank & Trust left its Aratana Therapeutics, Inc. share count unchanged in Q1 2015.
  • Aratana Therapeutics, Inc. made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #786 holding.
  • Boston Private Bank & Trust first reported a position in Aratana Therapeutics, Inc. in Q4 2014 and has held it in 2 quarters since.
  • Boston Private Bank & Trust's Aratana Therapeutics, Inc. position peaked at $15K in Q4 2014.
  • 93 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.